Published in TB and Outbreaks Week, January 6th, 2004
In the January 2004 issue of Nature Immunology, scientists report that certain "friendly" gut bacteria help us to put out the "fire" started by harmful bacteria using a unique mechanism. This finding opens new avenues for designing drugs to treat chronic inflammation in the gut.
Our cells respond to harmful bacteria by using a key, known as NF-kappaB, to turn on the machinery (DNA transcription) that manufactures inflammation-causing proteins. However, Kelly and colleagues from the Rowett...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.